During the last session, Compugen Ltd (NASDAQ:CGEN)’s traded shares were 0.32 million, with the beta value of the company hitting 2.60. The 52-week high for the CGEN share is $3.03, that puts it down -88.2 from that peak though still a striking 55.9% gain since the share price plummeted to a 52-week low of $0.71. The company’s market capitalization is $144.15M, and the average intraday trading volume over the past 10 days was 0.52 million shares, and the average trade volume was 295.08K shares over the past three months.
Compugen Ltd (CGEN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. CGEN has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.07.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Compugen Ltd (NASDAQ:CGEN) trade information
The stock’s 5-day price performance is -2.42%, and it has moved by 1.26% in 30 days. Based on these gigs, the overall price performance for the year is 107.47%. The short interest in Compugen Ltd (NASDAQ:CGEN) is 1.27 million shares and it means that shorts have 6.42 day(s) to cover.
The consensus price target of analysts on Wall Street is $4, which implies an increase of 59.75% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $4 and $4 respectively. As a result, CGEN is trading at a discount of -148.45% off the target high and -148.45% off the low.
Compugen Ltd (CGEN) estimates and forecasts
Statistics show that Compugen Ltd has outperformed its competitors in share price, compared to the industry in which it operates. Compugen Ltd (CGEN) shares have gone down -22.22% during the last six months, with a year-to-date growth rate more than the industry average at 152.38% against 17.10. In the rating firms’ projections, revenue will increase 53.49% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 24.96M as predicted by 2 analyst(s).
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 12.14%. While earnings are projected to return 82.54% in 2024.
CGEN Dividends
Compugen Ltd is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 1.31 million shares, is of TAYLOR FRIGON CAPITAL MANAGEMENT LLC’s that is approximately 1.4685% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $2.21 million.
